Related Experiment Video
Updated: Sep 3, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors
Martha Elena Díaz-Hernández1,2, Christopher W Kinter1,2, Shana R Watson1,2
1Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
Abstract:
Many metabolic bone diseases arise as a result excessive osteoclastic bone resorption, which has motivated efforts to identify new molecular targets that can inhibit the formation or activity of these bone-resorbing cells. Mounting evidence indicates that the transcription factor Runx1 acts as a transcriptional repressor of osteoclast formation. Prior studies using a conditional knockout approach suggested that Runx1 in osteoclast precursors acts as an inhibitor of osteoclastogenesis; however, the effects of upregulation of Runx1 on osteoclast formation remain unknown. In this study, we investigated the skeletal effects of conditional overexpression of Runx1 in preosteoclasts by crossing novel Runx1 gain-of-function mice (Rosa26-LSL-Runx1) with LysM-Cre transgenic mice. We observed a sex-dependent effect whereby overexpression of Runx1 in female mice increased trabecular bone microarchitectural indices and improved torsion biomechanical properties. These effects were likely mediated by delayed osteoclastogenesis and decreased bone resorption. Transcriptomics analyses during osteoclastogenesis revealed a distinct transcriptomic profile in the Runx1-overexpressing cells, with enrichment of genes related to redox signaling, apoptosis, osteoclast differentiation, and bone remodeling. These data further confirm the antiosteoclastogenic activities of Runx1 and provide new insight into the molecular targets that may mediate these effects.
Insights
Overexpressing Runx1 in female mice enhanced bone health by delaying osteoclast formation and reducing bone resorption. This study reveals Runx1
Area of Science:
- Bone Biology and Metabolism
- Cellular and Molecular Biology
- Genetics and Genomics
Background:
- Metabolic bone diseases often stem from excessive osteoclast-mediated bone resorption.
- The transcription factor Runx1 is implicated as a repressor of osteoclast formation.
- Previous studies suggest Runx1 inhibits osteoclastogenesis, but its upregulation effects are unknown.
Purpose of the Study:
- To investigate the skeletal effects of conditional Runx1 overexpression in preosteoclasts.
- To explore the molecular mechanisms underlying Runx1's role in osteoclastogenesis.
- To identify potential therapeutic targets for metabolic bone diseases.
Main Methods:
- Generation of novel Runx1 gain-of-function mice (Rosa26-LSL-Runx1).
- Crossbreeding with LysM-Cre transgenic mice for conditional overexpression in preosteoclasts.
- Analysis of bone microarchitecture, biomechanical properties, and transcriptomics.
Main Results:
- Runx1 overexpression in female mice led to increased trabecular bone indices and improved biomechanical properties.
- These improvements were associated with delayed osteoclastogenesis and reduced bone resorption.
- Transcriptomic analysis revealed altered gene expression related to redox signaling, apoptosis, and bone remodeling.
Conclusions:
- Runx1 exhibits anti-osteoclastogenic activity, confirming its inhibitory role in bone resorption.
- Runx1 overexpression in females positively impacts bone health through specific molecular pathways.
- These findings offer new insights into Runx1's therapeutic potential for bone diseases.
More Related Videos
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Formation by Endochondral Ossification